Delegations set to support global outreach of Australian biotech and medtech
AusBiotech will be leading missions to the world’s largest and most relevant biotech and medtech events over the coming months - in Shanghai, Hong Kong, Korea and USA - to support Australian companies in their outreach and global development.
Registration is now open for Australian delegations to:
- Biotech Invest Korea at the BioKorea International Convention, to be held in Seoul, Korea, from 8-10 April 2015;
- Australian Pavilion at the China International Medical Equipment Fair, 15-18 May 2015 in Shanghai, China;
- Asia Biotech Invest, 19-21 May 2015 in Kowloon, Hong Kong; and
- Australian Pavilion at the BIO International Convention, 15-18 June 2015 in Philadelphia, USA.
The Australian pavilions will offer exhibiting companies more than just an exhibition space, with packages of total support. The recognisable Brand Australia images, shared services, informal meeting areas, meeting rooms and reception counters will ensure you maximise your chances of achieving a successful outcome at these major events.
The investment missions showcase Australian companies for partnering and investing opportunities. Participation in these events, in many cases, is subsided by government support, making the costs of participation lower than attending alone.
You may be eligible to claim some of your marketing and promotion costs associated with the exhibitions through the Export Market Development Grant scheme. For more information, visit www.austrade.gov.au.
Some state governments also provide financial assistance to exporters to attend international exhibitions, such as Victoria’s Trade Mission Assistance Program. Please contact your local state development office to discuss applicable programs.
For more information on each event, see www.ausbiotech.org/events and click on ‘International’ for a full list of upcoming opportunities
Light at night can increase heart disease risk
Being exposed to bright light at night can significantly increase your chances of developing...
Scientists find new driver of ovarian cancer spread
A cell surface receptor known as F2R could serve as both a diagnostic marker for ovarian cancer...
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...

